|Bid||219.00 x 800|
|Ask||220.00 x 900|
|Day's Range||209.23 - 219.72|
|52 Week Range||118.11 - 219.72|
|Beta (5Y Monthly)||0.91|
|PE Ratio (TTM)||113.84|
|Earnings Date||Aug. 25, 2020 - Aug. 31, 2020|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||175.00|
Veeva (VEEV) delivered earnings and revenue surprises of 13.79% and 3.82%, respectively, for the quarter ended April 2020. Do the numbers hold clues to what lies ahead for the stock?
Veeva Systems Inc. (NYSE: VEEV), a leading provider of industry cloud solutions for the global life sciences industry, today announced results for its fiscal first quarter ended April 30, 2020.
Veeva Systems' (VEEV) core Subscription business segment performed impressively in Q1.
NEW YORK, NY / ACCESSWIRE / May 28, 2020 / Veeva Systems, Inc. (NYSE:VEEV) will be discussing their earnings results in their 2021 First Quarter Earnings call to be held on May 28, 2020 at 4:30 PM Eastern ...
Veeva (VEEV) is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP heading into earnings season.
Veeva Systems' (VEEV) fiscal first-quarter results are likely to reflect solid show by its segments and robust product portfolio.
SEOUL, South Korea , May 25, 2020 /CNW/ -- Veeva Systems (VEEV) today announced that the International Vaccine Institute (IVI), a not-for-profit International Organization established in 1997 as an initiative by the United Nations Development Programme (UNDP), has implemented Veeva Vault QualityDocs to improve control and real time visibility of standard operating procedures (SOPs) for audits and inspections. The move from paper-based processes to Vault QualityDocs will better enable IVI to meet compliance and GxP requirements of major drug administrations.
Veeva (VEEV) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Alnylam and Pfizer to discuss how innovative oncology and specialty medicines are transforming commercial models and helping improve patients' lives
Three no-brainer tech stocks that are poised to benefit as companies accelerate plans for a cloud-based digital future are Veeva Systems (NYSE: VEEV), Okta (NASDAQ: OKTA), and Arista Networks Inc (NYSE: ANET). As cloud software started to become mainstream, Veeva CEO and co-founder Peter Gassner realized that there weren't quality software solutions for the highly regulated life sciences industry, so he started the company in 2007.
A new partner program helps CROs build studies faster with Veeva Vault EDC. Ten global CROs, including 5 of the top 7 largest CROs, have joined.
MyVeeva is a free application for sites with capabilities for virtual patient visits, patient adherence, ePRO, eConsent, eSource, and a patient portal
Veeva Vault Site Connect automates the flow of information between sponsors and clinical research sites during clinical trials.
Amazon (NASDAQ: AMZN) and Microsoft (NASDAQ: MSFT) are often considered the top stocks in the cloud market. After all, Amazon Web Services (AWS) and Microsoft's Azure are the two largest cloud infrastructure platforms in the world, and both companies are leveraging their sprawling ecosystems to gain more customers. Amazon and Microsoft are still great investments, but investors shouldn't neglect other promising plays on the public cloud market, which could grow at a compound annual growth rate of 21% between 2018 and 2022, according to Forrester Research.
Crossix, the industry leader in patient data, privacy, and analytics, announced today that it has joined the Network Advertising Initiative (NAI).
Veeva Systems (NYSE: VEEV) and Salesforce (NYSE: CRM) are two closely linked companies in the cloud-based CRM (customer relationship management) space. Salesforce, which was founded 21 years ago, is the world's largest CRM company. In 2007, Peter Gassner, Salesforce's former senior VP of technology, co-founded Veeva to develop dedicated CRM solutions for pharmaceutical and life science companies.
The coronavirus pandemic has sent many stocks into freefall, and for good reason -- many companies have had to cut back their operations and lay off workers due to restrictions and lockdowns. Investors should consider buying these stocks that are poised for even bigger gains this year. Veeva Systems (NYSE: VEEV) stock is up 42% this year, largely thanks to its cloud business.